- Bitwise files an updated XRP ETF with NYSE listing.
- XRP price surges post-announcement.
- Trading could begin within 20 days if approved.
Bitwise Asset Management updated its XRP ETF application, indicating a potential NYSE listing with a 0.34% fee, as XRP’s price and market interest surge.
This reflects growing institutional interest in XRP amid increased trading activity, highlighting potential shifts in ETF offerings and market dynamics.
Bitwise made an update to its XRP ETF application, proposing a listing on the NYSE. The proposed management fee is 0.34%, as detailed in their SEC filing for Bitwise’s registration statement. The updated filing is seen as an important move for facilitating broader institutional investment.
Leading this effort is Bitwise, with key players including CEO Hunter Horsley and CIO Matt Hougan. They have previously made significant contributions to crypto asset management. While no official statements have been released, the amendment may indicate strategic growth plans.
The filing has sparked increased market activity for XRP globally. Prices rose to $2.51 as optimism grew among investors. In general, exchanges and investors are closely observing regulatory responses to the ETF amendment.
This filing may introduce changes in trading strategies and institutional interest. A successful approval could lead to expanded crypto asset access, driving further engagement from investment funds wanting diversified portfolios. “No public commentary or response regarding Bitwise’s XRP ETF has emerged yet,” said Raoul Pal, Key Opinion Leader.
The potential market entry of the Bitwise XRP ETF requires close scrutiny of regulatory protocols. Approval is scheduled for October 20, 2025. This date represents an essential deadline that might shape market strategies and investor expectations globally.
Drawing from past trends, XRP ETFs in Canada previously led to considerable price surges. This historical context suggests that a U.S. approval could similarly influence XRP’s market dynamics. Continued investor focus on regulatory and market developments remains pivotal.
